MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancer

Drug Resistance Updates · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles